“DMD Clinical Trials: An Overview” Presentation by TRiNDS
This presentation by Lauren Morgenroth, CGC and Ana Christensen, MPH at TRiNDS is part of the “A Holistic View of Clinical Trials” webinar and covers the following topics: the clinical […]
This presentation by Lauren Morgenroth, CGC and Ana Christensen, MPH at TRiNDS is part of the “A Holistic View of Clinical Trials” webinar and covers the following topics: the clinical […]
Webinar Information PepGen presents an overview of its enhanced delivery oligonucleotide platform and how this innovative platform technology is being applied to create a transformative exon skipping therapy. James McArthur, […]
This webinar covers the following topics: Understanding the Clinical Trial Process Managing Expectations Featured Speakers: Ana Christensen, MPH – TRiNDS and Italfarmaco Leslie Porter – Family, Duchenne Advocate Michael Kelly, […]
What is the role of exercise in patients with Duchenne Muscular Dystrophy? Special guest, Dr. Aaron S. Zelikovich, MD Original Webinar date: February 23, 2021Please submit your questions or comments […]
Enhancing Muscle Delivery of ASOs to treat Duchenne Dyne is excited to present an overview of their FORCETM platform and DMD drug development program to the Duchenne community and then […]
El impacto de Duchenne en la familia TEMAS: Genética Salud y afrontamiento del portador genético Planificación familiar Hablar con familiares / amigos / médicos / profesores Impacto financiero Se le […]
This presentation by Kimberly Nugent, CGC at Children’s Hospital of San Antonio is part of The Family Unit webinar and covers the following topics: genetic carrier health, carrier testing options […]
This webinar is a roundtable with scientific and medical experts covering recent updates to COVID-19 vaccines and how they relate to the Duchenne community. You’ll be prompted to enter your […]
In this webinar, Sarepta Therapeutics discusses their commitment to individuals living with Duchenne and the community. They provide an overview of their RNA Exon-Skipping therapies as well as Sarepta’s patient […]